ATLANTA – A sweeping trade pact between a dozen Pacific nations remains within reach, Japanese officials said Monday.
Participants continued talks in Atlanta to narrow final gaps in time for a scheduled joint news conference to announce the deal late Monday.
A ministerial session of the 12 nations for a Trans-Pacific Partnership agreement was scheduled to reconvene somewhere between 8 p.m. and 9 p.m. Japan time after a delay in a final agreement as New Zealand and Canada were negotiating details on tariffs on dairy products, an area that had earlier been believed close to agreement, the officials said.
A final deal was put on hold also because final details of the agreement’s wording were being worked out and the representatives were communicating with officials back home, they added.
The nations on Sunday came close to a final deal but failed to finalize terms on the fifth day of round-the-clock talks, dashing hopes raised by an earlier breakthrough on protections for new biotech drugs.
U.S. officials, who are hosting the meeting, delayed a planned joint news conference until early Monday.
That pushed a resolution of the Trans-Pacific Partnership talks beyond the deadline set by Japan’s economy minister Akira Amari. On Saturday, Amari had said the next 24 hours would be a make-or-break period for the talks.
After five years of negotiations, many officials had described this round as the best chance for an agreement, so failure to strike a deal in Atlanta would plunge the future of the talks into uncertainty.
Australian Trade Minister Andrew Robb said the delay on Sunday came as other TPP partners reviewed the proposed terms of a compromise on the monopoly period available for drug companies that develop new drugs known as biologics.
New Zealand negotiators also pressed on Sunday for greater access to overseas markets for its dairy exports, people involved in the talks said. “The thing that’s missing is (an agreement) on dairy market access,” one official said.
The sudden stall in the pace of talks came after organizers had set up a platform in the conference center decorated with flags of the TPP delegations for the announcement of a deal. By Sunday night, a U.S. government website that had been scheduled to live stream the ministerial news conference was carrying a banner saying “delayed pending further notice.”
On Sunday morning, Amari said he had called Prime Minister Shinzo Abe to notify him that a deal was within sight.
The TPP would lower tariffs and set common standards for 12 countries that represent a combined 40 percent of the global economy.
U.S. President Barack Obama has pushed for a deal as a way to open markets to U.S. exports, including financial services and pharmaceuticals. U.S. officials have also promoted the deal as a counterweight to China.
The issue of protections for new biologic medicines like Genentech’s Avastin cancer therapy has pitted the U.S. against Australia and five other countries.
The U.S. has pushed for longer monopoly protections for pharmaceutical companies to encourage innovation. Australia has countered that such measures would strain national health care budgets and keep life-saving medicines from patients who cannot afford them.
The U.S. provides 12 years of exclusivity for biologic drugs. Australia has insisted on five years of protection to control health care costs.
A two-track compromise hammered out by Australia and the U.S. would set a minimum threshold of five years during which drugmakers would have exclusive rights to clinical data behind new drugs while adding an additional protection of several more years as applications for competing drugs are reviewed, people involved said.
Under a second track, pharmaceutical companies would have eight years of exclusive rights to a new product outright in some countries, they said.
It was still unclear how that set of standards would influence pricing for future drugs. It was also unclear if other delegations, including Peru and Chile, would endorse the proposal.
Separately, the U.S. and Japan had reached agreement in principle on trade in autos and auto parts in talks that also included Canada and Mexico. That agreement is expected to give U.S. automakers, led by General Motors and Ford, extended tariff protection against low-cost pickup truck imports from Asia, people briefed on the talks have said.
But it would also give Japan’s auto industry, led by Toyota Motor Corp., a freer hand to source parts from Asia, including from plants outside the TPP-zone like China, on vehicles sold in North America.
A “rule of origin” would stipulate that only 45 percent of a vehicle would have to be sourced from within the TPP, down from the equivalent ratio of 62.5 percent under NAFTA, officials have said.
The announcement of a deal on Monday would mark the start of what could be a close-fought battle to ratify it in Congress.
Many Democrats and labor groups have raised questions about what the TPP would mean for jobs in manufacturing and environmental protections. Meanwhile Republicans, including Sen. Orrin Hatch, the powerful chairman of the Senate finance committee, have urged the administration to hold the line on intellectual property protections, including for drugs.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.